Abstract
Sickle hemoglobinemia, a term which refers to the presence of sickle hemoglobin (Hb-S) in either the heterozygous or homozygous form, has been associated with numerous and widely varying forms of disordered renal function, the majority of which are ultimately a consequence of the sickling process. In the presence of hypoxia, acidosis, or hyperosmolality (which causes red cells to shrink, thereby increasing intracellular hemoglobin concentration), the rate of gelation and tactoid formation increases and red cells become sickled (1–5). When this morphologic change occurs in the capillary bed there is an increase in blood viscosity. Resistance to blood flow is thereby increased, passage of red cells through capillaries is further delayed, and more deoxygenation and sickling ensue. This process, which has been described as ‘a vicious cycle of erythrostasis’(6), can eventually lead to ischemia and infarction of tissue. In the relatively hypoxic, acidic, and hyperosmolar environment of the renal medulla, such a process will eventually produce obliteration of the vasa recta, focal scarring, medullary interstitial fibrosis, papillary necrosis, and tubular atrophy which are the pathologic hallmarks of sickle-cell nephropathy (7–11). It is this widespread pathologic disruption of renal medullary anatomic integrity that accounts for most of the renal disorders that afflict patients with sickle hemoglobinemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Murayama M: Molecular mechanism of red cell ‘sickling’. Science 153: 145–149, 1966.
Greenberg MS, Kass EH, Castle WB: Studies on the destruction of red blood cells. XII. Factors influencing the role of S hemoglobin in the pathologic physiology of sickle cell anemia and related disorders. J Clin Invest 36: 833–843, 1957.
May A, Huehns ER: The concentration dependence of the oxygen affinity of haemoglobin S. Br J Haematol 30: 317–335, 1975.
Bookchin RM, Balazs T, Landau LC: Determinants of red cell sickling: effects of varying pH and of increasing intracellular hemoglobin concentration by osmotic shrinkage. J Lab Clin Med 87: 597–616, 1976.
Perillie PE, Epstein FH: Sickling phenomenon produced by hypertonic solutions: a possible explanation for the hyposthenuria of sicklemia. J Clin Invest 42: 570–580, 1963.
Ham TH, Castle WB: Relation of increased hypotonic fragility and of erythrostasis to the mechanism of hemolysis in certain anemias. Trans Assoc Am Physicians 55: 127–132, 1940.
Statius van Eps LW, Pinedo-Veels C, de Vries GH, de Koning J: Nature of concentrating defect in sickle-cell nephropathy: microradioangiographic studies. Lancet 1: 450–452, 1970
Sydenstricked VP, Mulherin WA, Houseal RW: Sickle cell anemia. Report of two cases in children, with necropsy in one case. Am J Dis Child 26:132–154, 1923.
Mostofi FK, Vorder Bruegge CF, Diggs LW: Lesions in kidneys removed for unilateral hematuria in sickle-cell disease. Arch Pathol 63: 336–351, 1957.
Pitcock JA, Muirhead EE, Hatch FE, Johnson JG, Kelly BJ: Early renal changes in sickle cell anemia. Arch Pathol 90: 403–410, 1970.
Buckalew VM Jr, Someren A: Renal manifestations of sickle cell disease. Arch Intern Med 133: 660–669, 1974.
Herrick JB: Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 6: 517–521, 1910.
Keitel HG, Thompson D, Itano HA: Hyposthenuria in sickle cell anemia: a reversible renal defect. J Clin Invest 35: 998–1007, 1956.
Schlitt L, Keitel HG: Pathogenesis of hyposthenuria in persons with sickle cell anemia or the sickle cell trait. Pediatr 26: 249–254, 1960.
Statius van Eps LW, Schouten H, ter Haar Romeny- Wachter CC, la Porte-Wijsman LW: The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chem Acta 27: 501–511, 1970.
Levitt MF, Hauser AD, Levy MS, Polimeros D.: The renal concentrating defect in sickle cell disease. Am J Med 29: 611–622, 1960.
Whitten CF, Younes AA: A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children. J Lab Med 55: 400–415, 1960.
Hatch FE, Culbertson JW, Diggs LW: Nature of the renal concentrating defect in sickle cell disease. J Clin Invest 46: 336–45, 1967.
Lief PD, Sullivan A, Goldberg M: Physiological contributions of thin and thick loops of Henle to the renal concentrating mechanism. J Clin Invest 48: 52a, 1969.
Statins van Eps LW, Schouten H, la Porte-Wijsman LW, Struyker Boudier AM: The influence of red blood cell transfusions on the hyposthenuria and renal hemodynamics of sickle cell anemia. Clin Chim Acta 17: 449–461, 1967.
Abel MS, Brown CR: Sickle cell disease with severe hematuria simulating renal neoplasm. JAMA 136: 624–625, 1948.
Goodwin WE, Alston EF, Semans JH: Hematuria and sickle cell disease: unexplained, gross unilateral, renal hematuria in negroes, coincident with the blood sickling trait. J Urol 63: 79–96, 1950.
Lucas WM, Bullock WH: Hematuria in sickle cell disease. J Urol 83: 733–741, 1960.
Sharpe AR Jr, Fox PG Jr, Dodson AI Sr: Unilateral renal hematuria associated with sickle cell C disease and sickle cell trait: Study of five patients and review of literature. J Urol 81: 780–783, 1959.
Moffat DB, Fourman J: The vascular pattern of the rat kidney. J Anat 97: 543–553, 1963.
Thorbum GD, Kopald HH, Herd JA, Hollenberg M, O’Morchoe CCC, Barger AC: Intrarenal distribution of nutrient blood flow determined with Krypton85 in the unanesthetized dog. Circ Res 13: 290–307, 1963.
Bernstein J, Whitten CF: A histological appraisal of the kidney in sickle cell anemia. Arch Pathol 70: 407–418, 1960.
Pitcock JA, Muirhead EE, Hatch FE, Johnson JG, Kelly BJ: Early renal changes in sickle cell anemia. Arch Pathol 90: 403–410, 1970.
Harrow BR, Sloane JA, Liebman NC: Roentgenologic demonstration of renal papillary necrosis in sickle-cell trait. N Engl J Med 268: 969–976, 1963.
Eckert DE, Jonutis AJ, Davidson AJ: The incidence and manifestations of Urographie papillary abnormalities in patients with S hemoglobinopathies. Radiol 113: 59–63, 1974.
Pandya KK, Koshy M, Brown N, Presman D. Renal papillary necrosis in sickle cell hemoglobinopathies. J Urol 115: 497–501, 1976.
Margulies SI, Minkin SD: Sickle cell disease. The roentgenologic manifestations of urinary tract abnormalities in adults. Amer J Roentgen Rad Ther and Nucl Med 107: 702–710, 1969.
Khademi M, Marquis JR: Renal angiography in sickle-cell disease. A preliminary report correlating the angiographic and Urographie changes in sickle-cell nephropathy. Radiol 107: 41–46, 1973.
Karayalcin G, Dorfman J, Rosner F, Aballi AJ: Radiological changes in 127 patients with sickle cell anemia. Am J Med Sei 271: 132–144, 1976.
Kimmelstiel P: Vascular occlusion and ischemic infarction in sickle cell disease. Am J Med Sei 216: 11–19, 1948.
Femi-Pearse D, Odunjo EO: Renal cortical infarcts in sickle-cell trait. Br Med J 3: 34, 1968.
Miller WA, Peck D, Lowman RM: Perirenal hematoma in association with renal infarction in sickle cell trait. Radiol 92: 351–352, 1969.
Sickles EA, Korobkin M: Perirenal hematoma as a complication of renal infarction in sickle-cell trait. Am J Roentgenol 122: 800–803, 1974.
Whalley PJ, Martin FG, Pritchard JA: Sickle cell trait and urinary tract infection during pregnancy. JAMA 189: 903–906, 1964.
Parhak UN, Tang K, Williams LL, Stuart KL. Bacteriuria of pregnancy: results of treatment. J Inf Dis 120: 91–95, 1969.
Amin UF, Ragbeer MS: The prevalence of pyelonephritis among sicklers and nonsicklers in an autopsy population. West Ind Med J 21: 166, 1972.
Whalley PJ, Pritchard JA, Richards JR Jr. Sickle cell trait and pregnancy. JAMA 186: 1132–1135, 1963.
Ho Ping Kong H, Alleyne GAO: Defect in urinary acidification in adults with sickle-cell anemia. Lancet 11: 954–955, 1968.
Ho Ping Kong H, Alleyne GAO: Studies on acid excretion in adults with sickle-cell anemia. ClinSci 41: 505–518, 1971.
Goossens JP, Statins van Eps LW, Schouten H, Giterson AL: Incomplete renal tubular acidosis in sickle cell disease. Clin Chim Acta 41: 149–156, 1972.
Oster JR, Lee SM, Lespier LE, Pellegrini EL, Vaamonde CA: Renal acidification in sickle cell trait. Arch Intern Med 136: 30–35, 1976.
DeFronzo RA, Taufield PA, Black H, McPhedran P, Cooke CR: Impaired renal tubular potassium secretion in sickle disease.. Ann Intern Med 90: 310–316, 1979.
Ho Ping Kong H, Alleyna GAO: Acid-Base status of adults with sickle-cell anemia. Br Med J 3: 271–273, 1969.
Battle D, Itsarayoungyven K, Arruda JAL, Kurtzman NA: Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Amer J Med 72: 188–192, 1982.
Rosansky SJ, Kennedy M: Sickle cell trait with episodic acute renal failure and Type IV renal tubular acidosis (letter). Ann Intern Med 93: 643, 1980.
Finkelstein FO, Haylett JP: Role of medullary structures in the fimctional adaptation of renal insufficiency. Kidney Int 6: 419–425, 1974.
Gold MS, Williams JC, Spivack M, Grann V: Sickle cell anemia and hyperuricemia. JAMA 206: 1572–1573, 1968.
Diamond H: Renal handling of uric acid in sickle cell anemia. Adv Exp Med Biol 41B: 759–762, 1973.
Diamond HS, Meisel A, Sharon E, Holden D, Cacatian A: Hyperuricosuria and increased tubular secretion of urate in sickle cell anemia. Am J Med 59: 796–802, 1975.
Etteldorf JN, Tuttle AH, Clayton GW: Renal function studies in pediatrics. 1. Renal hemodynamics in children with sickle cell anemia. Am J Dis Child 83: 185–191, 1952.
Diamond H, Meisel A, Holden D, Sharon E, Cacatian A, Virdi R: Hyperuricemia in Sickle Cell Anemia. In: Hercules JI, Schecter AN, Eaton WA, Jackson RE (eds) Proceedings, First National Symposium on Sickle Cell Anemia. Bethesda, Maryland, Department of Health, Education, and Welfare, Publication No. 75–723, 1974, p 371.
de Jong PE, de Jong-van den Berg LTW, Statins van Eps LW: The tubular reabsorption of phosphate in sickle-cell nephropathy. Clin Sci Mol Med 55: 429–434, 1978.
Hatch FE Jr, Azar SH, Ainsworth TE, Nardo JM, Culbertson JW: Renal circulatory studies in young adults with sickle cell anemia. J Lab Clin Med 76: 632–640, 1970.
Etteldorf JN, Smith JD, Tuttle AH, Diggs LW: Renal hemodynamic studies in adults with sickle cell anemia. Am J Med 18: 243–248, 1955.
Henderson AB: Sickle cell anemia. Clinical study of fifty- four cases. Am J Med 9: 757–765, 1950.
Berman LB, Schreiner GE: Clinical and histologic spectrumof the nephrotic syndrome. Am J Med 24: 249–267, 1958.
Berman LB, Tublin I: The nephropathies of sickle-cell disease. Arch Intern Med 103: 602–606, 1959.
McCoy RC: Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. Lab Invest 21: 85–95, 1969.
Miller RE, Hartley MW, Clark EC, Lupton CH Jr: Sickle cell nephropathy. Alab J Med Sci 1: 233–238, 1964.
Sweeney MJ, Dobbins WT, Etteldorf JN: Renal disease with elements of the nephrotic syndrome associated with sickle cell anemia. A report of 2 cases. J Pediatr 60: 42–51, 1962.
Elfenbein IB, Patchefsky A, Schwartz W, Weinstein AG: Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am J Pathol 77: 357–376, 1974.
Walker BR, Alexander F, Birdsall TR, Warren RL: Glomerular lesions in sickle cell nephropathy. JAMA 215: 437–440, 1971.
Pardo V, Straus J, Kramer H, Ozawa T, Mcintosh RM: Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients. Am J Med 59: 650–659, 1975.
Strom T, Muehrcke RC, Smith RD. Sickle cell anemia with the nephrotic syndrome and renal vein obstruction. Arch Intern Med 129: 104–108, 1972.
Nicholson GD, Amin UF, Brooks SEH, Alleyne GAO: End-stage renal failure in sickle cell trait. West Ind Med J 28: 235–239, 1979.
Strauss J, Koss M, Griswold W, Chemack W, Pardo V, Mcintosh RM: Cryoprecipitable immune complexes, nephropathy, and sickle-cell disease (letter). Ann Intern Med 81: 114–115, 1974.
Strauss J, Pardo V, Koss MN, Griswold W, Mcintosh RM: Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. I Studies on nature of glomerular-bound antiobody and antigen identification in a patient with sickle cell disease and immune deposit glomerulonephritis. Am J Med 58: 382–387, 1975.
Ozawa T, Mass MF, Guggenheim S, Strauss J, Mcintosh RM: Autologous immune complex nephritis associated with sickle cell trait: Diagnosis of the haemoglobinopathy after renal structural and immunological studies. Br Med J 1: 369–71, 1976.
Ellis JT: Glomerular lesions and the nephrotic syndrome in rabbits given saccharated iron oxide intravenously. J Exp Med 103: 127–144, 1956.
Ellis JT: Glomerular lesions in rabbits with experimentally induced proteinuria as disclosed by electron microscopy. Am J Pathol 34: 559–560, 1958.
Friedman EA, Sreepada Rao TK, Sprung CL, Smith A, Manis T, Bellevue R, Butt KMH, Levere RD, Holden DM: Uremia in sickle-cell anemia treated by maintenance hemodialysis. N Engl Med 291: 431–435, 1974.
Powers DR: Natural history of sickle cell disease - the first ten years. Semin Hemat 12: 267–285, 1975.
Gerry JL Jr, Bulkley BH, Hutchins GM: Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia. Am J Cardiol 42: 211–216, 1978.
Koppes GM, Daly JJ, Coltman CA Jr, Butkus DE: Exertion-induced rhabdomyolysis with acute renal failure and disseminated intravascular coagulation in sickle cell trait. Am J Med 63: 313–317, 1977.
Evans PV, Symmes AT: Bone marrow infarction with fat embolism and nephrosis in sickle cell disease. J Indiana Med Assoc 50: 1101–1105, 1957.
Motulsky AG: Frequency of sickling disorders in U.S. blacks. N Engl J Med 288: 31–33, 1973.
Rosa RM, Bierer BE, Thomas R, Stoff JS, Kruskall M, Robinson S, Bunn HF, Epstein FH: A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis. N Engl J Med 303: 1138–1143, 1980.
Knöchel JP: Hematuria in sickle cell trait: the effect of intravenous administration of distilled water, urinary alkalinization, and diuresis. Arch Intern Med 123: 160–165, 1969.
Immergut MA, Stevenson T: The use of epsilon amino caproic acid in the control of hematuria associated with hemoglobinopathies. J Urol 93: 110–111, 1965.
Sweeney WM: Aminocaproic acid, inhibitor of fibrinolysis. Am J Med Sci 249: 576–589, 1965.
Brody JI, Levison SP, Jung CJ: Sickle cell trait and hematuria associated with von Willebrand syndromes. Ann Intern Med 86: 529–533, 1977.
Weinger RS, Benson GS, Villarreal S: Gross Hematuria associated with sickle cell trait and von Willebrand’s disease. J Urol 122: 136–137, 1979.
Spector D, Zachary JB, Sterioff S, Millan J: Painful crises following renal transplantation in sickle cell anemia. Am J Med 64: 835–839, 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston / The Hague / Dordrecht / Lancaster
About this chapter
Cite this chapter
Rosa, R.M. (1984). Therapy of Renal Disorders in Sickle Hemoglobinemia. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3807-9_29
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3807-9_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3809-3
Online ISBN: 978-1-4613-3807-9
eBook Packages: Springer Book Archive